Contact lens manufacturer representatives discussed the state of the contact lens industry, including consumer education, doctor-patient communication, and legislative battles. Scot Morris, OD, FAAO, posed questions during the Global Contact Lens Forum at Vision Expo East.
Johnson & Johnson Vision Care (JJVC) has discontinued its unilateral pricing policy (UPP) in an effort to focus the company’s resources on strengthening the doctor-patient relationship and advocating against contact lens deregulation. In UPP’s place, JJVC will be launching a new patient rewards program. This change is effective April 13, 2016.
Athletes have many vision challenges, but contact lenses can meet many of their needs on the court, field, or pitch, says Niall Farnon, MCOptom, when he presented at SECO 2016.
As a die-hard University of Kentucky basketball fan, I have watched many, many basketball games throughout my life. During these basketball games, I have cringed at a few of my favorite players because I have seen some of the players drop their contact lenses on the court, pick them up, put them in their mouths, and then put them right back in their eyes!
Didn’t make it to Atlanta for SECO this year? That’s OK—we’ve got you covered. Check out all the latest news you may have missed.
We have been the fortunate recipients of innovative technologies in contact lenses that were only concepts a mere decade ago. As a profession, we transitioned most of our two-week and monthly disposable contact lens wearers who were in traditional hydrogel materials into silicone hydrogel materials.
When we take a step back and think about what happens in our offices—in our exam rooms—we realize what a huge impact we have, dare I say “control,” on the growth of our contact lens practice. Yet so many elements of our everyday operations challenge that control and cause us to forget or push to the side the techniques we know to grow our contact lens business.
Bausch + Lomb, a Valeant Pharmaceuticals company, has acquired Alden Optical Laboratories. The acquisition is the latest in a series of moves by Bausch + Lomb that sent ripples through the gas permeable subset of the contact lens industry.
In a recent filing, Dallas-based gas permeable (GP) contact lens laboratory TruForm Optics has taken legal action against Valeant Pharmaceuticals. The class-action complaint aims to stop competitive behavior, obtain damages for past competitive behavior, and to restore competitive market conditions.
Valeant Pharmaceuticals and its subsidiary Bausch + Lomb have come under fire for its recent actions in purchasing competing gas permeable (GP) contact lens manufacturer Paragon Vision Sciences, attempts to purchase independent GP laboratories, price increases, and withdrawal from industry support group Contact Lens Manufacturers Association (CLMA).